How long does stem cell therapy for Chronic Wounds & Ulcers last?
The durability of closure depends heavily on the underlying cause, perfusion, infection control, pressure relief and metabolic management. Current heterogeneous cell studies do not establish a universal recurrence rate or maintenance schedule. Follow-up should use protocol-defined durable-closure and safety measures while standard wound care continues.
How stem cells are studied for Chronic Wounds & Ulcers
Chronic wounds—including diabetic foot ulcers, pressure injuries and vascular ulcers—may fail to close because of impaired perfusion, infection, pressure, metabolic disease and disrupted inflammatory and repair processes. Cells and extracellular vesicles are being studied for proposed effects on immune signalling, angiogenesis, fibroblasts and extracellular matrix in preclinical models. Those mechanisms have not established durable closure or limb salvage in people. Diagnosis and treatment of infection, ischaemia, pressure and the underlying disease remain essential. The registry table on this page lists relevant studies and their current recruitment status.
Am I a candidate? → · Chronic Wounds & Ulcers: full overview → · Chronic Wounds & Ulcers cost → · Cost →
Evidence checked against ISSCR, FDA and EMA guidance. See our editorial standards. This is information, not medical advice. Educational information, not medical advice; figures indicative.
Sources & further reading
More on this condition
- Chronic Wounds & Ulcers: cell-therapy evidence and registered trials
- How much does stem cell therapy for Chronic Wounds & Ulcers cost? (2026)
- Chronic Wounds & Ulcers stem cell therapy — your questions answered (2026)
- Chronic Wounds & Ulcers: cell-therapy evidence by therapy class
- MSC vs PRP for Chronic Wounds & Ulcers: what the registries show